The up-regulation of RIPK1 expression and activity in neurodegenerative diseases has been demonstrated by numerous studies both in postmortem human samples and transgenic mice [44,46,52,63,81,82]. The gene discussed is RIPK1; the disease is neurodegenerative disease.